Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue

使用 iPSC 衍生神经组织的新型生物工程模型研究细胞类型特异性阿尔茨海默病遗传变异

• 批准号: 9980545
• 负责人: PHILIP G HAYDON
• 金额: $ 97.59万
• 依托单位: TUFTS UNIVERSITY BOSTON
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-05-01 至 2025-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/9980545
• 关键词: 3-Dimensional; Abeta clearance; Action Potentials; Affect; Aging; Alleles; Alzheimer like pathology; Alzheimer' s Disease; Alzheimer' s disease brain; Alzheimer' s disease pathology; Alzheimer' s disease patient; Alzheimer' s disease risk; Amyloid beta-42; Amyloid beta-Protein; Animal Disease Models; Animal Model; Apolipoprotein E; Apolipoproteins; Architecture; Astrocytes; Axon; Binding; Biomedical Engineering; Brain; Cell Culture Techniques; Cell Density; Cell Line; Cell Surface Proteins; Cell Transplantation; Cell model; Cells; Cholesterol Homeostasis; Code; Cognitive; Collagen; Complement; Complex; Data; Deterioration; Diffusion; Electrophysiology (science); Family; Functional disorder; Gene Expression; Genes; Genetic Polymorphism; Genotype; Growth; Homeostasis; Human; In Vitro; Late Onset Alzheimer Disease; Learning; Link; Mammals; Memory; Memory impairment; Metabolic; Microglia; Modeling; Mus; Mutation; Myeloid Cells; Necrosis; Neonatal; Nerve Degeneration; Neurodegenerative Disorders; Neuroglia; Neurons; Nutrient; Optics; Oxygen; Pathogenesis; Pathologic; Patients; Phagocytosis; Phenotype; Physiological; Population; Porifera; Proteins; Risk; Risk Factors; Rodent; Senile Plaques; Silk; Sleep; Synapses; Synaptic Transmission; Synaptic plasticity; System; TREM2 gene; Technology; Time; Tissue Model; Tissues; Transplant Recipients; Transplantation; Variant; abeta deposition; apolipoprotein E-4; base; beta secretase; brain behavior; cell type; early onset; exome; extracellular; familial Alzheimer disease; genetic variant; genome editing; genome sequencing; genome wide association study; human subject; in vivo; induced pluripotent stem cell; innovation; lipid metabolism; member; molecular phenotype; mutant; neuronal excitability; novel; precursor cell; receptor; relating to nervous system; risk variant; scaffold; stem cell technology; synaptic function; synaptogenesis; three dimensional cell culture; trafficking; whole genome

ABSTRACT Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by memory impairments and cognitive deterioration. Aging is the major risk factor for AD. Furthermore, increasing evidence indicates that astrocytes and microglia are implicated in the pathogenesis of AD. The ε4 allele of the apolipoprotein E gene (APOE) has been identified as a major risk factor contributing to the pathogenesis of sporadic AD (SAD) in about 15-20% of the cases. APOE is the major apolipoprotein expressed in the human brain primarily by astrocytes and to a lesser extent by microglia, and is involved in cholesterol homeostasis, and regulates A clearance. Furthermore, genome-wide association studies (GWAS) have identified polymorphisms in genes enriched in microglia (e.g. SORL1, CR1, CD2AP, CD33, TREM2, ABCA7) and astrocytes (e.g. CLU and ABCA7) that increase the risk of developing AD. Recent advances in stem cell technology have allowed the reprogramming of primary cells from human subjects into induced pluripotent stem cells (iPSCs) and their differentiation in neurons, astrocytes and microglia. However, conventional 2D culture systems fail to recapitulate the diversity and maturation of multiple cell types and their interaction under physiological and pathological conditions. To overcome these weaknesses we have developed a novel bioengineered model of iPSC-derived neural tissue. Our silk-collagen protein-based ‘donut’ scaffolds can support compartmentalized, 3D brain-like tissues over a year, without necrosis. This tissue model is highly innovative, supporting the differentiating neurons growth in a donut-shaped porous silk sponge within an optically cleared collagen-filled central region for axon connectivity and synapse formation, that will allow for the first time live in vivo studies (e.g., cell-based electrophysiology, trafficking, synaptic functionality) of an human AD brain-like tissue during ageing (months of cultivation) under controlled experimental conditions. More importantly, the architecture of the scaffolds was optimized to meet the metabolic demand of high-density cell cultures in terms of free diffusion of nutrients and oxygen, a fundamental requisite for long-term cultures and ageing-related studies. Thus, we propose to: 1) Assess genotype-phenotype relationship of AD genetic variants enriched in astrocytes and microglia in patient-derived 3D brain-like cultures; 2) Assess genotype-phenotype relationship of AD genetic variants in vivo after transplantation of patient-derived cells in mice.

抽象的 阿尔茨海默氏病（AD）是一种以记忆障碍为特征的进行性神经退行性疾病 和认知决心。衰老是AD的主要危险因素。此外，越来越多的证据表明 星形胶质细胞和小胶质细胞在AD的发病机理中施加。载脂蛋白E的ε4等位基因 基因（APOE）已被确定为有助于零星AD发病机理的主要危险因素（SAD） 在大约15-20％的情况下。 ApoE是在人脑中表达的主要载脂蛋白。 星形胶质细胞和小胶质细胞的程度较小，参与胆固醇稳态，并调节A 清除。此外，全基因组关联研究（GWAS）已经确定了基因的多态性 富含小胶质细胞（例如SORL1，CR1，CD2AP，CD33，TREM2，ABCA7）和星形胶质细胞（例如Clu和Clu和 ABCA7）增加了发展广告的风险。干细胞技术的最新进展使 从人类受试者中重编程原代细胞为诱导的多能干细胞（IPSC）及其 神经元，星形胶质细胞和小胶质细胞的分化。但是，传统的2D培养系统无法 概括多种细胞类型的多样性和成熟及其在生理和 病理状况。为了克服这些弱点，我们开发了一种新颖的生物工程模型 IPSC衍生的神经组织。我们的丝绸 - 胶原蛋白基于蛋白质的“甜甜圈”脚手架可以支持分隔的， 3D脑样组织一年，没有坏死。该组织模型具有高度创新性，支持 在光学清除胶原蛋白的胶原蛋白中，在甜甜圈形的多孔丝绸赞助商中区分神经元的生长 轴突连通性和突触形成的中央区域，这将首次允许体内研究 （例如，基于细胞的电生理学，运输，突触功能）在人类AD脑样组织中 在受控的实验条件下衰老（几个月培养）。更重要的是， 优化脚手架以满足自由的高密度细胞培养的代谢需求 营养和氧的扩散，这是长期培养和与年龄相关的研究的基本必需品。 也就是说：1）评估富含星形胶质细胞的AD遗传变异的基因型 - 表型关系 和患者衍生的3D脑样培养物中的小胶质细胞； 2）评估AD的基因型 - 表型关系 小鼠患者衍生细胞移植后体内遗传变异。